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ABSTRACT 
Using a Tecan robotic sample processor and IBM compatible PCs we have 
developed a flexible, partially automated radioligand binding assay system. 
It handles pipetting parameters of up to 16 saturation or competition ex- 
periments at a time with up to 24 radioligand- or competitor-concentrations 
in a range over 4 orders of magnitude per experiment. The system pro- 
vides enough flexibility so that all pipetting parameters including different 
tube-, rack-sizes, sample volumina and pipettin sequences may be easily 
assays. It rationalizes and increases assay throughput (up to 70% spare of 
working time), improves reliance and reproducibility of results. Radioactive 
exposure is minimized to the time preparing the radioligand working solu- 
tion and transferring the sample tubes to and from the sample processor. 
The system has proven effective in various investigations on binding inter- 
actions, as well as in clinical studies on receptor expression under physio- 
logic, pathological and therapeutic conditions. 
adapted to the large variety of experimenta B requirements in binding 
INTRODUCTION 
Binding assays with radiolabeled drugs are used to measure and 
characterize the interactions of ligands with a variety of receptors for hor- 
mones, neurotransmitters and drugs. Over the past two decades radio- 
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370 LIEBL ET AL. 
ligand binding techniques have become increasingly important in clinical 
research and in the pharmaceutical industry as an essential part in drug 
discovery and evaluation. In clinical investigations receptor expression is 
studied in tissue samples from healthy, sick, untreated or treated subjects 
with the aim of correlating changes in their characteristics to the patho- 
physiology and pharmacotherapy of diseases. In the process of drug dis- 
covery the technique allows in vitro targeting of a distinct receptor thought 
to be involved in the pathophysiology of a given disease which thus may 
yield important information regarding selectivity, specifity and/or affinity of 
novel compounds intended for use as therapeutic drugs (1). 
A wide range of assays have been developed. Applications in clini- 
cal research often involve the study of variations in the expression of va- 
rious receptors in dynamic situations where receptor properties may alter 
along a timescale and profile measurements are necessary, for example in 
drug-response or circadian studies. In order to measure these alterations 
effectively, it is necessary to take samples for assay at set intervals over a 
certain time period, e.g. before and after drug application. In most cases 
this means that many assays have to be performed within a short time for 
each patient, thus necessitating rapid sampling and assay techniques 
which generally involves a variety of experimenters working on the same 
system. In the drug development process many thousands of compounds 
have to be screened before one can be introduced as new drug. 
Valid results may only be obtained under well defined, standar- 
dized experimental conditions which in turn may differ largely depending 
on various experimental protocols. The scatter of data points is a most 
critical experimental parameter and validity therefore highly depends on the 
reproducibility of the results which in turn relies upon the accurancy and 
precision of the assay steps involved. Ligand binding assays are tedious 
procedures involving a large number of pipetting steps combined with ra- 
dioactive exposure of the lab personnel. Manual pipetting techniques have 
considerable potential for dispensing imprecision and error associated with 
liquid carry over and contamination. In addition, when several workers are 
involved in a study, the variation in pipetting skills leads to additional error. 
There has been considerable interest in the automation of such 
procedures but because of the variety of assays, it has not previously been 
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RADIOLIGAND BINDING ASSAY SYSTEM 371 
possible to develop a flexible and satisfying system. Using a robotic 
sample processor and a personal computer (PC) we have developed a 
partially automated radioligand binding assay system which rationalizes 
and increases assay throughput, improves reliance and reproducibility of 
results, reduces radioactive exposure and frees lab workers from time- 
consuming pipetting jobs. 
ASSAY SYSTEM 
We have designed a software (EBSS = equilibrium binding studies 
software) for IBM compatible PCs controling a Tecan Robotic Sample Pro- 
cessor Model 5032 (dual arm system). The system handles pipetting para- 
meters of two types of experiments, saturation or competition experiments 
(up to 16 single assays at a time). Up to 24 concentrations of a radioligand 
or competing compound in a range over 4 orders of magnitude may be de- 
fined per experiment. An additive (e.g. antioxidans) may be supplemented 
to all samples uniformly. Pipetting may be performed alternatively in 1 of 3 
different tube or rack types, respectively, with total sample volumes 
between 200 and 2000 ul. Depending on the desired pipetting volumina, 
the syringes of the sample processor are adapted to achieve maximal pi- 
petting precision (& 2 % of nominal value). The pipetting sequence can be 
altered, automatic pipettes may be switched on or off so that certain pipet- 
ting steps may be performed by hand or at a later point of time (e.g. tissue 
pipette, if samples are prepared for an experiment which is to be started 
later by tissue addition). 
All parameter inputs are menu controlled. A hardcopy of the 
screens with three main input menus defining assay parameters (for the 
example described later) are shown in FIG. 1 - 3. Depending on substance- 
specific constants (molecular weights, specific activity) and experiment- 
specific variables (volumes, concentrations) required reagent-dilutions (ra- 
dioiigand, competing compounds, additive) and titertube arrangements are 
displayed. The pipetting steps in performance are displayed and may be 
printed on a hardcopy device together with exact time course informations. 
The system provides enough flexibility so that all pipetting parame- 
ters can easily be adapted to the large variety of experimental requirements 
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ARM 1 (left) tip@) 1 (syr 1 + 2) ARM 2 (left) tip(s) 
syringe@) 2 (right) 2500 UI 
4 (syr 1) 
SYfhQe(S) 1 (left) 4 X UI 
pie 20 uI 
ING tissue 
FIG. 1 : Screen-hardcopy of input menu defining processor configuration. 
material and liquid handling parameters. 
FIG. 2: Screen-hardcopy of input menu defining substance- and tissue- 
specific parameters. 
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RADIOLIGAND BINDING ASSAY SYSTEM 373 
FIG. 3: Screen-hardcopy of input menu describing one competition ex- 
periment. Up to 16 different experiments are possible per run. 
in binding assays. All parameters can be saved in so-called method files 
and loaded bypassing the input functions, they may be copied, deleted or 
revised and saved anew. Other options allow a parameter-listing or the ge- 
neration of an ASCII-format file which may be later combined with radioacti- 
vity measurements for data analysis. 
If separation of bound from unbound radioactivity is performed by 
centrifugation, the system may be additionally used for removal of the 
supernatant. 
APPLICATIONS 
The advantages of the system is demonstrated in the following by 
a set of competition experiments which were performed in our lab for cha- 
racterization of binding sites for 125iodocyanopindolol (1251CYP) in human 
peripheral mononuclear leucocytes (MNL) (2-5). 
Jo
ur
na
l o
f R
ec
ep
to
rs
 a
nd
 S
ig
na
l T
ra
ns
du
ct
io
n 
D
ow
nl
oa
de
d 
fro
m
 in
fo
rm
ah
ea
lth
ca
re
.c
om
 b
y 
U
ni
ve
rs
ity
 o
f R
eg
en
sb
ur
g 
on
 0
2/
17
/1
1
Fo
r p
er
so
na
l u
se
 o
nl
y.
374 LIEBL ET AL. 
Using the sample processor three competition experiments (in tri- 
plicates) with 8, 24 and 95 pmol/l 1251CYP, respectively, and 21 concentra- 
tions of isoprenaline in the concentration range of - lo-’ mol/l were 
prepared. Total and unspecific binding (in duplicates) were determined in 
parallel samples with and without mol/l of (-)-timolol. Alltogether 70 
specimens per experiment (21 0 alltogether) were prepared with varying 
volumes of buffer, various isoprenaline dilutions, a constant volume of 
radioligand- (100 ul) and timolol-solution (20 ul) as well as 200 ul of cell- 
suspension to achieve a total reaction volume of 1000 ul. FIG. 1 - 3 show 
hardcopies of the input screens for assay-parameter definition for one of 
these experiments. 
Before introduction of the assay system in our lab one person was 
employed for at least 4 hours for sample preparation for such a set of ex- 
periments, while another lab worker was occupied with cell preparation. 
Using the processor sample preparation could be achieved by a single ex- 
perimenter parallel to preparation of MNL by density gradient centrifuga- 
tion. After parameter definition, working time for sample preparation was 
reduced to arranging the titer tubes (1 ml BioradR in microtiterplate-sized 
racks) and preparing stock solutions for radioligand and competing com- 
pounds (isoprenaline, timolol) according to instructions from the program. 
Automatic pipetting of one experiment took about 10 minutes. 
Experiments were started by adding 200 ul pMNL suspension in a 
concentration of 5 x lo6 cells/ml to each of the 210 specimens. After incu- 
bation in a waterbath (2 h, 37°C) the sample-racks were centrifuged at 
5000 g for 10 minutes and transferred back to the lab robot. Bound radio- 
activity was separated from the unbound ligand by removing the superna- 
tant by the machine. Compared to the conventional rapid filtration-method 
over glass fiber filters this procedure saved material (no filters necessary), 
time and radioactive exposure of the experimenters. 
The radioactive counts were evaluated using a PC. Due to the pi- 
petting precision of the sample robot scatter of data points was in the 
range of & 4 % of the mean value. To determine the binding parameters 
(binding capacity Bmax, and Bmax, for high and low affinity binding sites, 
the respective equilibrium dissociation constants Ki, / Ki, for isoprenaline 
and Kd, / Kd, for ‘251CYP)(2) data were mathematically fitted to a binding 
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FIG. 4: Competition curves for isoprenaline with 3 1251CYP-concentrations. 
8,: specific binding, Bmax,: 510 sites/cell, Bmax,: 9180 sites/cell; 
KI : 2.6x107, Ki : 4 . 2 ~ 1 0 ~  (isoprenaline), Kd,: 1 ~ 1 0 ' ~  mol/l, Kd,: 
2.4~109 (1251~~  8). 
equation for two classes of binding sites using a computer-based nonlinear 
iteration procedure (FIG. 4). 
A summarized comparison of time consumption and exposure to 
radioactivity with and without use of sample processor and PC is given in 
TABLE 1. Alltogether 70 % of working time was saved (84 min compared to 
302 min). Radioactive exposure was minimized to the time of transferring 
the sample racks from the robot to the waterbath, to the centrifuge and 
back to the robot. After preparing the radioligand working solution no fur- 
ther direct contact with radioactivity was necessary. 
The assay system has been applied in several clinical studies (e.g. 
circadian and drug-response studies) on receptor expression under phy- 
siologic, pathological and therapeutic conditions. Results from these inves- 
tigations have been published elsewere (6-1 1). They implied multiple satu- 
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376 LIEBL ET AL. 
TABLE 1. 
Comparison of time consumption and exposure to radioactivity (- = none, 
+ = low, + + + + = high) with and without use of sample processor and PCs 
for 3 competion experiments (21 concentrations in triplicates each). 
TASK 
WITHOUT SAMPLE- WITH SAMPLE- 
PROCESSOR AND PC 
total working radioact. total working radioact. 
time time exposure time time exposure 
(rnin) (min) (min) (min) 
PROCESSOR AND PC 
cell preparation by density 120 
gradient centrifugation 
inscription of tubes 30 
arrangement of tubes in racks 10 
calculation of dilutions 20 
prepare stock dilutions 15 
prepare intermediate dilutions 15 
pipetting 60 tubes (radio- 90 
ligand, buffer,displacer,cells) 
transfer to waterbath, 120 
incubation 
transfer to, load centrifuge 12 
centrifugation, unload centrifuge 
separation bound from 20 
free radioactivity 
load radioactivity-counter 125 
and counting 
raw data analysis 60 
nonlinear iterativ curve fit not possible - 10 
30 
30 
10 
20 
10 
15 
90 
5 
2 
20 
5 
60 
+ +  
+ + + +  
+ 
+ 
+ t +  
120 
5 
15 
30 
120 
10 
10 
125 
5 
SUM 637 302 
30 
5 
15 + +  
5 
5 t 
1 + 
3 
5 
5 
10 
- 
450 84 
ration experiments, for example at 4 hour intervals and 30, 60, 120, 180, 
240 and 360 minutes after drug application. Up to 14 experiments with 12 
radioligand concentrations per experiment had to be performed within 36 
hours for each subject (8, 10). Without the lab robot 2 persons were busy 
for 1 day preparing the assays for such a study (inscription of titer tubes, 
arranging them in racks, making reagent dilutions, pipetting jobs). By 
employing the lab robot preparation time was reduced to about 4 h and 
could be achieved by a single technician parallel to other tasks in the 
course of the study. 
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RADIOLIGAND BINDING ASSAY SYSTEM 377 
The system has also proven effective in the research department of 
a major German pharmaceutical company. It is applied there for the 
screening of novel compounds for possible binding interaction using the 
option of performing multiple competition experiments (up to 16 per run) 
with a small number of concentrations (1 to 4) per substance to be 
investigated. The responsible scientists report that the same number of ex- 
periments which previously afforded 3 technicians is performed now by a 
single person in half of the time. 
CONCLUS IONS 
Radioligand binding assays are a well established technique in 
pharmacological research. They are technically simple to perform, but 
time-consuming and prone to error if performed manually. Valid infor- 
mation is only obtained if conditions are carefully controlled. Using a 
robotic sample processor and IBM compatible PCs a flexible, partially auto- 
mated assay system has been developed which rationalizes and increases 
assay throughput, improves reliance and reproducibility of results and mini- 
mizes radioactive exposure of experimenters. 
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